Ionis Pharmaceuticals | IONS - Fremdkapital





Fremdkapital Veränderung Datum
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.47B 6.56M 2026-06
Arrowhead Research USD 824.07M 401.34M 2026-06
Astellas Pharma JPY 320B 0 2026-06
BioCryst Pharmaceuticals USD 395.4M 203K 2026-06
BioMarin Pharmaceutical USD 3.53B 2.1B 2026-06
Celltrion KRW 411.27B 998.23M 2026-03
Cspc Pharmaceutical CNY 180.69M 21.94M 2025-12
Deva Holding AS TRY 559.97M 44.39M 2023-09
Divis Laboratories Ltd INR 50M 30M 2026-03
Halozyme Therapeutics USD 1.94B 1.79M 2026-06
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
Kangmei Pharma CNY 68.57M 9.87M 2026-03
Knight Therapeutics CAD 57.78M 26.92M 2025-12
Laboratorios Farma EUR 80.5M 28.26M 2024-12
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 1.5M 167K 2025-12
Moderna USD 597M 6M 2026-06
Nektar Therapeutics USD 60.27M 2.89M 2026-03
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 37.49B 42M 2026-06
Omeros USD 403.72M 27.2M 2024-06
OPKO Health USD 336.03M 1.08M 2026-03
Organigram Holdings CAD 60.76M 1.77M 2026-03
Ovoca Bio EUR 0 0 2021-06
Pfizer USD 60.5B 70M 2026-06
Pharma Mar EUR 32.13M 1.04M 2026-06
PTC Therapeutics USD 535.52M 248.58M 2026-06
Qiagen NV USD 1.63B 19.45M 2026-06
Regeneron Pharmaceuticals USD 1.99B 400K 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
Sarepta Therapeutics USD 847.62M 9.46M 2026-06
Sartorius EUR 3.65B 311.1M 2026-06
Sino Biopharmaceutical CNY 3.08B 1B 2025-06
Tilray USD 268.59M 3.82M 2025-09
Ultragenyx Pharmaceutical USD 1.13B 19M 2026-03
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12
Zealand Pharma A/S 307M 76.14M 2026-03
Zz Pientze Pharmaceu CNY 182.29M 4.27M 2026-03